Liz Cole-Greenblatt

Liz Cole-Greenblatt serves as a key procurement professional within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic acquisition of scientific, diagnostic, and operational capabilities. She manages a diverse portfolio of contracts enabling laboratory diagnostics, biomedical research, and data-driven public health infrastructure, with a focus on rapid-response technologies and high-complexity scientific services. Her work directly supports CDC’s core functions in infectious disease surveillance, epidemiological analysis, and laboratory capacity building, ensuring timely access to mission-critical resources across federal, state, and local health systems. She maintains sustained relationships with leading contractors including General Dynamics Information Technology, GlaxoSmithKline, MRIGLOBAL, and Cepheid, partnering with both large industry players and specialized scientific service providers. These collaborations center on advanced diagnostic platforms, clinical research support, and public health data systems, reflecting a preference for vendors with proven expertise in biosafety, regulatory compliance, and high-throughput analytical technologies. Her contracting approach emphasizes performance-based outcomes and technical rigor, ensuring alignment with CDC’s scientific standards and emergency response requirements. Her procurement strategy prioritizes open competition, with 85.2% of awards issued without set-asides, indicating a strong focus on technical merit and mission necessity over socioeconomic preferences. Nevertheless, she consistently allocates 14.8% of awards to total small business set-asides under FAR 19.5, demonstrating a balanced commitment to fostering innovation from small businesses while maintaining operational readiness. Her primary NAICS focus includes Medical Laboratories (621511), Software Publishers (513210), and All Other Professional, Scientific, and Technical Services (541990), reflecting deep expertise in procuring diagnostic testing systems, public health software platforms, and specialized scientific consulting services. She frequently acquires next-generation molecular diagnostics, laboratory information management systems, and epidemiological analytics tools, underscoring her technical proficiency in advancing CDC’s data-centric public health mission.